CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sosei Group Corporation Company Snapshot
Sosei Group Corporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sosei Group with three other companies in this sector in Japan: Takara Bio Inc (2017 sales of 29.38 billion Japanese Yen [US$262.32 million] of which 90% was Bio support), Morishita Jintan Co., Ltd. (10.97 billion Japanese Yen [US$97.94 million] of which 71% was Health Care Business), and Shin Nippon Biomedical Laboratories Ltd (17.24 billion Japanese Yen [US$153.99 million] of which 75% was Pre-Clinical Business).

Sales Analysis. Sosei Group reported sales of ¥18.90 billion (US$168.79 million) for the fiscal year ending March of 2017. This represents an increase of 131.9% versus 2016, when the company's sales were ¥8.15 billion. Sales at Sosei Group have increased during each of the previous five years (and since 2012, sales have increased a total of 2,092%). Sales of Overseas Pharmaceutical Business saw an increase of 136.3% in 2017, from ¥7.95 billion to ¥18.80 billion. Not all segments of Sosei Group experienced an increase in sales in 2017: sales of Demestic Pharmaceutical Business fell 48.2% to ¥102.00 million. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sosei Group Corporation
  Stock Performance Chart for Sosei Group Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 11,920
(Figures in Japanese Yen)
1 Week -1.2%   13 Weeks -4.4%  
4 Weeks 4.7%   52 Weeks -27.1%  
 
Sosei Group Corporation Key Data:
  Ticker: 4565 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 18,901,000,000
(Year Ending Jan 2018).
Employees: 145
  Currency: Japanese Yen Market Cap: 201,640,913,280
  Fiscal Yr Ends: March Shares Outstanding: 16,916,184
  Share Type: Common Closely Held Shares: 1,374,884
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.